Orthopaedics and Rheumatology Flashcards
Presentation of rheumatoid arthritis
- swollen, painful joints in the hands and feet
- stiffness worse in the morning
- gradually gets worse with larger joints becoming involved
What are the poor prognostic factors for rheumatoid arthritis?
- anti CCP
- rheumatoid factor
- early erosions on X ray (<2 years)
- HLA DR4
- Extra articular features
Management of rheumatoid arthritis
- dMARD with a bridging course of prednisolone
- methotrexate/sulfasalazine
- hydroxychloroquine if mild or palinodromic
How can you monitor response to treatment of rheumatoid arthritis?
- crp
- disease activity score e.g. DAS28
Management of flare of rheumatoid
corticosteroid
Indication for TNF-a in rheumatoid arthritis
Failed response to at least two dMARDs
Name 3 TNFa inhibitors
- etanercept
- infliximab
- adalimumab
X ray findings of rheumatoid arthritis
- loss of joint space
- juxta-articular osteoporosis
- soft tissue swelling
- periarticular erosion
- subluxation
methotrexate side effects
- myelosuppression
- pneumonitis
- liver cirrhosis
Side effects of sulfasalazine
- rashes
- oligospermia
- heinz body anaemia
- interstitial lung disease
hydroxychloroquine side effects
- retinopathy
- corneal deposits
What are the patterns of psoriatic arthritis?
- symmetric
- asymmetrical
- sacroillitis
- DIP joint disease
- arthritis mutilans
Signs of psoriatic arthritis
- psoriatic skin lesions
- periarticular disease: enthesitis, tenosynovitis, dactylitis
- nail changes: pitting, onycholysis
X ray psoriatic arthritis
- pencil in cup appearance
- periostitis
- erosive changes, new bone formation
Management of psoriatic arthritis
- NSAID if mild
- dMARD (methotrexate) if moderate or severe
- monoclonal antibodies such as ustekinumab (targets both IL-12 and IL-23) and secukinumab (targets IL-17)
Pseudogout
deposition of calcium pyrophosphate dihydrate crystals in the synovium
Risk factors of pseudogout
- haemochromotosis
- wilsons
- hyperparathyroidism
- acromegaly
- low magnesium, low phosphate
-age
Features of pseudogout
- knee, wrist, shoulder
- joint aspiration: weakly-positively birefringent rhomboid-shaped crystals
- x-ray: chondrocalcinosis
What are the main features of gout?
- pain
- swelling
- erythema
commonly affected joints in gout
- most commonly the 1st MTP joint
- others: ankle, wrist, knee
Investigations for gout
- measure the uric acid level if >360 supports the diagnosis, if under and symptoms still suggest gout then repeat in 2 weeks
- synovial fluid analysis (needle shaped negatively birefringent monosodium urate crystals)
What is the management of an acute flare of gout?
- NSAIDs
- Colchicine
- if the patient is already taking allopurinol they should continue taking it
What is the main side effect of colchicine?
Diarrhoea
Who should be started on urate lowering therapy and when?
Anyone who has had an attack of gout, two weeks after the attack
Management of gout to prevent an attack
- allopurinol
- lifestyle advice: avoid alcohol, lose weight if obese, avoid food high in purines: liver, oily fish, seafood, yeast products
When is urate lowering therapy particularly recommended?
- ≥2 attacks in the last 3 months
- tophi
- renal disease
- uric acid renal stones
- if on cytotoxics or diuretics
Typical joints osteoarthrtitis
- larger joints
- knee
- hip
- carpometocarpal
- DIP, PIP joints
X ray findings osteoarthritis
- loss of joint space
- subchondral sclerosis
- subchondral cysts
- osteophytes
What is the management of osteoarthritis
- weight loss, local muscle strengthening, general aerobic fitness advice
- topical NSAIDs
- second line: oral NSAIDs and PPI
- intra-articular steroid injections if analgesia not effective (pain relief only lasts 2-10 weeks)
- consideration of joint replacement
What are the most common causes of septic arthritis in adults?
- staph aureus
- n. gonnorhoeae in young adults who are sexually active
Features of septic arthritis
- acute, swollen joint
- warm to touch/fluctuant
- restricted movement
Investigations septic arthritis
- synovial fluid aspiration
- blood cultures
- joint imaging
Management of septic arthritis
- IV antibiotics
- flucloxacillin
- switch to oral antibiotics after 2 weeks
What is reactive arthritis
Arthritis that develops following an infection in which the organism cannot be recovered from the joint
STI reactive arthritis
- chlamydia
post dysenteric arthritis
- shigella
- salmonella
What is the management of reactive arthritis?
- analgesia, NSAIDs, intra-articular steroids
- sulfasalazine or methotrexate if continuing disease
Features of reactive arthritis
- typically develops within 4-6 weeks post infection
- asymmetrical oligoarthritis
- dactylitis
- urethritis
- conjunctivitis or anterior uveitis
- circinate balanitis (painless vesicles on the coronal margin of the prepuce)
keratoderma blenorrhagica (waxy yellow/brown papules on palms and soles)
What are the common features of the seronegative spondyloarthropathies?
- rheumatoid factor negative
- peripheral arthritis and usually asymmetrical
- sacroillitis
- enthesopathy
- extra- articular manifestations (uveitis, pulmonary fibrosis (upper zone), amyloidosis, aortic regurgitation)
What are the sero-negative spondyloarthropathies?
- ankylosing spondylitis
- psoriatic arthritis
- reactive arthritis
- enteropathic arthritis
Features of ankylosing spondylitis
- typically a young man with lower back pain and stiffness of insidious onset
- stiffness worse in the morning, better with exercise
- may experience pain at night which gets better on getting up
clinical exam ankylosing spondylitis
- reduced lateral flexion
- reduced forward flexion (schober’s test)
- reduced chest expansion
- the A’s: apical fibrosis, AV node block, anterior uveitis, aortic regurgitation, achilles tendonitis, amyloidosis
Investigation ankylosing spondylitis
- X ray of sacroiliac joints
- ESR and CRP may be raised
X ray ankylosing spondylitis
- sacroilitis: subchondral erosions, sclerosis
- sparing of lumbar vertebrae
- bamboo spine
- syndesmophytes
- chest x ray: apical fibrosis
Early sign of ankylosing spondylitis if X ray is negative
- bone marrow oedema on MRI
Management of ankylosing spondylitis
- regular exercise e.g. swimming
- NSAIDs are first line treatment
- physiotherapy
- disease modifying drugs can be used if there is peripheral arthritis
- anti- TNF if high level disease activity despite conventional treatments e.g. etanercept
Onset SLE
20-40
ethnicity SLE more common
Afro-Caribbean, asian
sensitivity reaction SLE
Type 3
Genes SLE
HLA B8, DR2, DR3
General features of SLE
- fatigue
- fever
- mouth ulcers
- lymphadenopathy
Skin features of SLE
- malar rash (butterfly)
- discoid rash
- photosensitivity
- raynauds
- livedo reticularis
- non scarring alopecia
msk features of SLE
- arthralgia
- non erosive arthritis
cardiovascular features of SLE
- pericarditis
- myocarditis
Respiratory features of SLE
- pleurisy
- fibrosing alveolitis
Renal features of SLE
- proteinuria
- glomerulonephritis
Neuropsychiatric features of SLE
- anxiety and depression
- psychosis
- seizures
Antibodies in SLE
- 99% are ANA positive (high sensitivity, low specificity
- anti- dsDNA (high specificity, sensitivity 70%)
- 20% rheumatoid factor positive
- anti-smith
- anti- Ro, anti-La
monitoring of SLE
- Inflammatory markers: ESR, crp
- complement C3/4 are low during activity of disease
- anti-ds DNA can be used
management of SLE
- NSAIDs
- sun block
- hydroxychloroquine
What are the 3 types of systemic sclerosis
- limited cutaneous
- diffuse cutaneous
- scleroderma (without internal organ involvement)
limited cutaneous sclerosis
- raynauds
- scleroderma affecting the face and distal limbs
- subtype= CREST: calcinosis, raynauds, esophageal dysmotility, sclerodactyly, telangiectasia
antibodies limited cutaneous sclerosis
anti-centromere antibodies
(ANA also positive in cutaneous sclerosis)
Diffuse cutaneous sclerosis
- scleroderma affecting the trunk and proximal limbs
- respiratory: ILD/pulmonary arterial hypertension
- renal disease and hypertension
What is scleroderma?
Thickening and tightening of the skin
What is sjogrens?
autoimmune disorder affecting the exocrine glands resulting in dry mucosal surfaces